Vol 3 (September 2020): Precision Cancer Medicine

Case Report
“Lazarus effect” in patient affected by lung adenocarcinoma carrying EGFR, CTNNB1, MET exon 11 and PIK3CA mutations treated with gefitinib
Nicole Conci, Filippo G. Dall’Olio, Vittoria Comellini, Stefano Brocchi, Rita Golfieri, Andrea Ardizzoni
Precision Cancer Medicine  
2020;
3:
23  
Case Report: Precision Oncology Tumor Board
Prolonged immune checkpoint inhibitor response of a patient with a RET rearranged non-small cell lung cancer and high tumour mutational burden: case report and review of the literature
Safiye Dursun, Tom E. J. Theunissen, Xiaofei Li, Ernst-Jan M. Speel, Lizza E. L. Hendriks
Precision Cancer Medicine  
2020;
3:
22  
Case Report: Precision Oncology Tumor Board
Trastuzumab-Pertuzumab resistance in a case of HER2-del16 expressing colorectal cancer—a case report
Sayak Ghatak, Kevin Lin, Emil Lou, Andrew C. Nelson
Precision Cancer Medicine  
2020;
3:
21  
Review Article
A narrative review of salvage therapy in small cell lung cancer
Saira Farid, Stephen V. Liu
Precision Cancer Medicine  
2020;
3:
20  
Editorial Commentary
Current and future perspectives in lung cancer prevention
Adrián González-Marrón, Juan Carlos Martín-Sánchez, Jose M. Martínez-Sánchez
Precision Cancer Medicine  
2020;
3:
18